ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO842

Inflammatory and Angiogenic Factors Associated with Microvascular Changes over a 6-Month Period in a Cohort of Hemodialysis Patients

Session Information

Category: Dialysis

  • 606 Dialysis: Epidemiology, Outcomes, Clinical Trials - Cardiovascular

Authors

  • Mitsides, Nicos, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom
  • Cornelis, Tom, Jessa General Hospital, Hasselt, Belgium
  • Broers, Natascha, Maastricht University Medical Centre , Maastricht, Netherlands
  • Diederen, Nanda, Maastricht University Medical Centre , Maastricht, Netherlands
  • Brenchley, Paul E., Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom
  • van der Sande, Frank, Maastricht University Medical Centre , Maastricht, Netherlands
  • Schalkwijk, Casper, Maastricht University Medical Centre , Maastricht, Netherlands
  • Kooman, Jeroen, Maastricht University Medical Centre , Maastricht, Netherlands
  • Mitra, Sandip, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom
Background

Cardiovascular (CV) disease is a major contributor to poor outcomes in haemodialysis (HD). Comorbidity & oxidative stress are confounding factors to this phenomenon. High Dose HD (HDHD) regimes have been linked with a CV benefit compared to Conventional HD (CHD). We investigate the relationship between HD intensity, pro-inflammatory & endothelial mediators and micro- & macrocirculatory parameters over a 6-month period.

Methods

We report the findings of the 6-month analysis of participants to the study of Uremic Toxins, Cardiovascular Effects & Physical Activity in Intensive Haemodialysis (INTHEMO); a 2yr multicentre study investigating the effects of HDHD on CV parameters. Macrocirculation was assessed with pulse wave velocity & 24hr ambulatory blood pressure measurements. Microcirculation was assessed using sublingual dark field capillaroscopy. A panel of pro-inflammatory & endothelial biomarkers added to the assessment of vascular health. Hydration state was assessed by means of multifrequency bio-impedance.

Results

Of the 47 followed up at over a 6-month period, 21 were performing HDHD (>12hr of haemodialysis per week) & 26 CHD. CHD participant were older (63.5±14.2 v 53.7±12.6yr; p=0.02), with a smaller dialysis vintage (median vintage 23, max-min 6-106 v 61, max-min 10-432 months; p<0.01) & better-preserved residual renal function (61.5% v 9.5%;p<0.01). HD intensity did not correlate to any changes to CV measurements over a 6-month period. Higher serum levels of IL 8 (median 14.3pg/ml, min-max 3.5-185.7) measured at baseline independently predicted increase in the Perfused Boundary Region (5-25μm) of the endothelial glycocalyx (β=0.408, p<0.01) while higher levels of soluble Flt-1 (median 253pg/ml, min-max 139-1434) had a significant inverse effect (β=0.408, p<0.01) in an adjusted multivariate linear regression model.

Conclusion

HD intensity did not predict any changes in either macro- or microvascular parameters in HD patients. Micro-inflammation mediated through the TNF-alpha & IL-8 pathway was a predictor of microvascular injury while Flt-1, a potential marker of angiogenesis & endothelial repair might have a significant protective role. Further exploration into the pathophysiological effects of these pathways is required.

Funding

  • Clinical Revenue Support